DOCSLIB.ORG

Alimentary Tract Proteinases of the Southern Corn

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Alimentary Tract Proteinases of the Southern Corn Durham E-Theses Alimentary tract proteinases of the Southern corn rootworm (Diabrotica undecimpunctata howardi) and the potential of potato Kunitz proteinase inhibitors for larval control. Macgregor, James Mylne How to cite: Macgregor, James Mylne (2001) Alimentary tract proteinases of the Southern corn rootworm (Diabrotica undecimpunctata howardi) and the potential of potato Kunitz proteinase inhibitors for larval control., Durham theses, Durham University. Available at Durham E-Theses Online: http://etheses.dur.ac.uk/3808/ Use policy The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that: • a full bibliographic reference is made to the original source • a link is made to the metadata record in Durham E-Theses • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders. Please consult the full Durham E-Theses policy for further details. Academic Support Oce, Durham University, University Oce, Old Elvet, Durham DH1 3HP e-mail: [email protected] Tel: +44 0191 334 6107 http://etheses.dur.ac.uk 2 Alimentary tract proteinases of the Southern corn rootworm (Diabrotica undecimpunctata howardi) and the potential of potato Kunitz proteinase inhibitors for larval control. The copyright of this thesis rests with the author. No quotation from it should be published without his prior written consent and information derived from it should be acknowledged. A thesis submitted by James Mylne Macgregor B.Sc. in accordance with the requirements of the University ofDurham for the degree ofDoctor of Philosophy. Department ofBiological Sciences, University of Durham. September 200 I. Abstract. Proteolytic digestion by larval Diabrotica undecimpunctata howardi (Barber) (D. undecimpunctata) has been investigated with the aim ofproducing transgenic plants possessing enhanced resistance to this economically important crop pest. Biochemical characterisation in vitro by pH dependent hydrolysis and inhibition assays incorporating E-64, pepstatin A and soybean Kunitz trypsin inhibitor showed the majority of hydrolytic activity occurs at pH 5.5 and is performed by cysteine and aspartic endopeptidases. Cysteine and aspartic proteinase encoding clones were isolated from a larval alimentary tract cDNA library. Four cathepsin L-like cysteine proteinases and two cathepsin D-like aspartic proteinase cDNA clones were identified by coding homology to known proteinase sequences. Analysis of primary and secondary sequence features revealed D. undecimpunctata aspartic proteinase 1 exhibits features associated with cathepsins E and is proposed to be a D. undecimpunctata cathepsin E-like aspartic proteinase. Cathepsin D-like aspartic proteinase inhibitors ofthe potato Kunitz proteinase inhibitor (PKPI) family have been isolated by PCR and expressed employing the pET expression system (Novagen). In vitro assays demonstrated the inhibitory activity of PKPI-A and PKPI-B inhibitors against larval D. undecimpunctata alimentary tract proteolytic enzymes. To the authors knowledge this work represents the first reporting of the expression and purification ofbiologically active PKPI proteins. In vitro assays incorporating oryzacystatin I and PKPI proteins resulted in increased inhibition of proteolytic activity compared to single inhibitor and uninhibited control reactions. Inhibition assays provide evidence for the potential ofadual proteinase inhibitor strategy to arrest protein hydrolysis by larval D. undecimpunctata, preventing essential amino acid absorption. Further research is necessary to characterise the properties ofthe digestive enzymes isolated in this work and the inhibitory spectrum ofPKPI proteins. Transgenic crops expressing a combination of oryzacystatin and PKPI proteins would be predicted to show enhanced resistance to insect herbivores by virtue of digestive proteolysis inhibition. Acknowledgements. I would like to express my appreciation for the financial support provided by the BBSRC and Syngenta PLC for this C.A.S.E studentship. My gratitude is also due to the Department of Biological Sciences, Durham University for the use of their facilities. My appreciation is extended to Dr John Gatehouse and Dr Jane Cayley for assistance and supervision during the pursuit of this project. My appreciation also goes to Gillian Davison for maintaining the D. undecimpunctata cultures and for being flexible with changing plans. Many thanks go to the following people; Ilona Bausch. Samantha Connors. Phi lip Pattison and Jaqueline Snowden Terry Pratchett for his obnoxious but accurate little phrase. Ana Gabriella Renetario Rojas. Vincent Townshend and Lynne Conlon. Also to Florence Reeves, Jack O'Grady and Colin Illet, who are sadly no longer with us. To my parents possibly the greatest thanks for their advice and support. II a. a. amino acid. bp base pair. cDNA copy deoxyribonucleic acid. D. undecimpunctata Diabrotica undecimpunctata howardi Barber. DNA deoxyribonucleic acid. EPPO European and Mediterranean Plant Protection Organisation. g gram. hr hour. L litre. M Molar. mm minute. MMLV-RT­ Moloney Murine Leukemia Virus reverse transcriptase. mRNA messenger ribonucleic acid. MCS multiple cloning site. O.D. optical density. PAGE polyacrylamide gel electrophoresis. PCR polymerase chain reaction. pfu plaque forming units. RNA ribonucleic acid. rpm revolutions per minute. sec second. Taq Thermus aquaticus. u.v. ultraviolet. v/v volume to volume ratio. w/v weight to volume ratio. IIl A adenine. c cytosine. G guanine. T thymine. A Ala Alanine c Cys Cysteine B Asx Asparagine or aspartic acid D Asp Aspartic E Glu Glutamic acid F Phe Phenylalanine G Gly Glycine H His Histidine I Ile Isoleucine K Lys Lysine L Leu Leucine M Met Methionine N Asn Asparagine p Pro Proline Q Gln Glutamine R Arg Arginine s Ser Serine T Thr Threonine V Vat Valine w Trp Tryptophan y Tyr Tyrosine z Glx Glutamine or glutamic acid IV Contents. Abstract. Acknowledgements. Il Abbreviations. Ill Amino Acid and base codes. TV Contents. V List offigures. XII Chapter 1. Introduction. 1 1.1. Summary; arable crops past present and future. 1 1.2. Genus Diabrotica; agricultural pests ofNorth America. 2 1.2.1. D. undecimpunctata life cycle and distribution. 4 1.2.2. Current Diabrotica control technologies. 6 1.3. Insect pesticide and xenobiotic detoxification. 8 1.3.1. Glutathione S-transferases. 10 1.3.2. Cytochrome P450 mixed function oxidases. 12 1.4. Biotechnology and crop protection. 15 1.4.1. Bacillus thuringiensis toxins. 16 1.4.2. Chitinases. 19 1.4.3. Proteinase inhibitors. 22 1.5. Plant proteinase inhibitors. 25 1.5.1. The 20-24 kDa proteinase inhibitors of potato. 26 1.5.2. The Cystatin superfumily. 29 1.6. Insect digestive physiology. 31 1.7. Transport and localisation ofproteinases. 33 1.8. Proteolytic enzymes. 37 1.8.1. Cysteine Proteinases. 38 1.8.2. Aspartic proteinases. 41 1.8.3. Serine proteinases. 43 V 1.8.4. Exopeptidases. 46 1.9. Plant inhibitors of D. undecimpunctata digestive proteinases. 47 1.10. Project aims. 48 Chapter 2. Materials and Methods. 49 2.1. Chemical and solution abbreviations. 49 2.2. Materials and software. 50 2.3. Frequently used media and solutions. 51 2.4. Methods. 55 2.5. Larval D. undecimpunctata culture. 55 2.6. Biochemical methodology. 55 2.6.1. Alimentary tract extraction. 55 2.6.2. Proteolysis assay system. 56 2.6.3. pH dependent proteolysis assays. 57 2.6.4. Proteolysis inhibition assays. 57 2.7. RNA extraction and analysis. 58 2.7.1 Larval gut dissection. 58 2.7.2. Total RNA extraction and purification. 58 2.7.3. mRNA extraction and purification. 58 2.7.4. RNA electrophoresis. 59 2.8. Polymerase chain reaction (PCR). 60 2.8.1. PCR primer design. 60 2.8.2. Reverse-transcriptase PCR. 60 2.8.3. Taq polymerase PCR. 61 2.8.4. Advantage 2 PCR. 62 2.8.5. Cloning PCR products. 62 VI 2.9. DNA manipulation and sequence analysis. 63 2.9.1. DNA electrophoresis. 63 2.9.2. Visualisation and photography ofEtBr stained gels. 63 2.9.3. Silica fines DNA gel slice purification. 63 2.9.4. Restriction endonuclease digestion ofDNA. 64 2.9.5. DNA ligation. 64 2.9.6. DNA sequencing. 65 2.9.7. DNA sequence data analysis. 65 2.10. Bacterial culture and plasmid isolation. 66 2.1 0.1. Overnight cultures. 66 2.1 0.2. Plasmid mini-preparations. 66 2.10.3. Glycerol stocks. 66 2.11. cDNA library construction and screening. 67 2.11 .1. cDNA library generation and evaluation. 67 2.11.2. Digoxigenin labelled cDNA probe generation. 68 2.11.3. cDNA library screening. 69 2.11.4. Antibody detection and visualisation of 71 hybridised probe. 2.11.5. Excision and circularisation ofpTripiEx 2 plasmid. 72 2.12. pET 24a construct preparation, recombinant protein 72 expression and analysis. 2.12.1. pET 24a expression vector construct generation. 72 2.12.2. Recombinant protein expression analysis. 73 2.12.3. Large scale recombinant protein expression. 74 2.12.4. Ni-NT A chromatography. 75 2.12.5. Oryzacystatin purification. 76 2.12.6. Dialysis of protein samples. 77 2.12.7. Protein freeze drying. 77 VII 2.12.8. SDS-PAGE analysis. 77 R.esulllts and! Discussion. Cllnapter3. lBiochemncal cllnarncterisatioi!B of D. undecimpMnctata 79 pD'oteollytic actnvnties. 3.0. Introduction 79 3.1. Results: pH optima of proteolytic activities in D. undecimpunctata 79 alimentary tracts. 3. 2. Results: Inhibition of D. undecimpunctata larval alimentary tract 82 proteolysis by chemical and plant protein proteinase inhibitors. 3. 3. Discussion. 84 Cllnapter4. Molecular isolatioiiD of larval D. undecimpunctata cysteine 86 and aspartic protennases. 4.0. Introduction. 86 4.1. Results: Isolation and identification of aspartic and cysteine proteinase 86 encoding sequence fragments from larval D. undecimpunctata. 4.2. Results: Isolation of cathepsin D and L cON A transcripts from the larval 106 D. undecimpunctata alimentary tract cDNA library. 4.2.1.
Load more

Recommended publications
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Inhibition of Mitochondrial Complex II in Neuronal Cells Triggers Unique
    www.nature.com/scientificreports OPEN Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration Sathyanarayanan Ranganayaki1, Neema Jamshidi2, Mohamad Aiyaz3, Santhosh‑Kumar Rashmi4, Narayanappa Gayathri4, Pulleri Kandi Harsha5, Balasundaram Padmanabhan6 & Muchukunte Mukunda Srinivas Bharath7* Mitochondrial dysfunction and neurodegeneration underlie movement disorders such as Parkinson’s disease, Huntington’s disease and Manganism among others. As a corollary, inhibition of mitochondrial complex I (CI) and complex II (CII) by toxins 1‑methyl‑4‑phenylpyridinium (MPP+) and 3‑nitropropionic acid (3‑NPA) respectively, induced degenerative changes noted in such neurodegenerative diseases. We aimed to unravel the down‑stream pathways associated with CII inhibition and compared with CI inhibition and the Manganese (Mn) neurotoxicity. Genome‑wide transcriptomics of N27 neuronal cells exposed to 3‑NPA, compared with MPP+ and Mn revealed varied transcriptomic profle. Along with mitochondrial and synaptic pathways, Autophagy was the predominant pathway diferentially regulated in the 3‑NPA model with implications for neuronal survival. This pathway was unique to 3‑NPA, as substantiated by in silico modelling of the three toxins. Morphological and biochemical validation of autophagy markers in the cell model of 3‑NPA revealed incomplete autophagy mediated by mechanistic Target of Rapamycin Complex 2 (mTORC2) pathway. Interestingly, Brain Derived Neurotrophic Factor
    [Show full text]
  • Untersuchung Zur Selektivität Der Hemmung Von Cathepsin L-Ähnlichen Cysteinproteasen Durch Die Dazugehörigen Propeptide
    Untersuchung zur Selektivität der Hemmung von Cathepsin L-ähnlichen Cysteinproteasen durch die dazugehörigen Propeptide Dissertation zur Erlangung des akademischen Grades doctor medicinae dentariae (Dr. med. dent.) vorgelegt dem Rat der Medizinischen Fakultät der Friedrich-Schiller-Universität Jena von Yvonne Benedix, geboren am 05. Februar 1979 in Karl-Marx-Stadt Gutachter 1 Gutachter 2 Gutachter 3 Tag der öffentlichen Verteidigung Inhaltsverzeichnis 3 Abkürzungsverzeichnis 5 Zusammenfassung 7 1. Einleitung 9 2. Materialien und Methodik 16 2.1. Materialien 16 2.1.1. Antibiotika, Chemikalien, Enzyme, Standards und Substrate 16 2.1.2. Kits zur Bearbeitung von DNA 17 2.1.3. Verwendete Vektoren und Bakterienstämme 17 2.1.4. Geräte 18 2.1.5. Spezielle Computerprogramme 19 2.2. Molekularbiologische Methoden 19 2.2.1. Amplifizierung der Proregionen von Cathepsin H und L 19 mittels PCR 2.2.2. DNA-Trennung im Agarosegel und Extraktion 21 2.2.3. Klonierung, Ligation, Transformation und DNA-Isolierung 21 2.2.4. DNA-Seqzenzanalyse 25 2.3. Proteinchemische Methoden 26 2.3.1. Expression und Reinigung der rekombinanten Propeptide 26 2.3.2. Reinigung der Einschlusskörperchen durch Saccharose- Dichtegradientenzentrifugation 27 2.3.3. Endreinigung des Propeptids durch Gelfiltration 28 2.3.4. Charakterisierung der rekombinanten Propeptide 29 2.3.5. Massenspektrometrie durch MALDI-TOF 31 2.4. Kinetische Messung 31 2.4.1. Testdurchführung 31 2.4.2. Bestimmung des KM-Wertes 33 2.4.3. Bestimmung der Inhibitionskonstanten Ki und koff 34 3. Ergebnisse 37 3.1. Herstellung der Propeptide von Cathepsin H (kurz), Cathepsin H (lang) und Cathepsin L 37 3.1.1.
    [Show full text]
  • Reticulum Mainly Localized in the Endoplasmic Predominantly
    Human Cathepsin W, a Cysteine Protease Predominantly Expressed in NK Cells, Is Mainly Localized in the Endoplasmic Reticulum This information is current as of September 24, 2021. Thomas Wex, Frank Bühling, Heike Wex, Dagmar Günther, Peter Malfertheiner, Ekkehard Weber and Dieter Brömme J Immunol 2001; 167:2172-2178; ; doi: 10.4049/jimmunol.167.4.2172 http://www.jimmunol.org/content/167/4/2172 Downloaded from References This article cites 44 articles, 18 of which you can access for free at: http://www.jimmunol.org/content/167/4/2172.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 24, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2001 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Human Cathepsin W, a Cysteine Protease Predominantly Expressed in NK Cells, Is Mainly Localized in the Endoplasmic Reticulum1 Thomas Wex,2,3*† Frank Bu¨hling,2§ Heike Wex,*‡ Dagmar Gu¨nther,¶ Peter Malfertheiner,† Ekkehard Weber,¶ and Dieter Bro¨mme3* Human cathepsin W (also called lymphopain) is a recently described papain-like cysteine protease of unknown function whose gene expression was found to be restricted to cytotoxic cells.
    [Show full text]
  • Cysteine Cathepsins: from Structure, Function and Regulation to New Frontiers☆
    Biochimica et Biophysica Acta 1824 (2012) 68–88 Contents lists available at SciVerse ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbapap Review Cysteine cathepsins: From structure, function and regulation to new frontiers☆ Vito Turk a,b,⁎⁎, Veronika Stoka a, Olga Vasiljeva a, Miha Renko a, Tao Sun a,1, Boris Turk a,b,c,Dušan Turk a,b,⁎ a Department of Biochemistry and Molecular and Structural Biology, J. Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia b Center of Excellence CIPKEBIP, Ljubljana, Slovenia c Center of Excellence NIN, Ljubljana, Slovenia article info abstract Article history: It is more than 50 years since the lysosome was discovered. Since then its hydrolytic machinery, including Received 16 August 2011 proteases and other hydrolases, has been fairly well identified and characterized. Among these are the cyste- Received in revised form 3 October 2011 ine cathepsins, members of the family of papain-like cysteine proteases. They have unique reactive-site prop- Accepted 4 October 2011 erties and an uneven tissue-specific expression pattern. In living organisms their activity is a delicate balance Available online 12 October 2011 of expression, targeting, zymogen activation, inhibition by protein inhibitors and degradation. The specificity of their substrate binding sites, small-molecule inhibitor repertoire and crystal structures are providing new Keywords: fi Cysteine cathepsin tools for research and development. Their unique reactive-site properties have made it possible to con ne the Protein inhibitor targets simply by the use of appropriate reactive groups. The epoxysuccinyls still dominate the field, but now Cystatin nitriles seem to be the most appropriate “warhead”.
    [Show full text]
  • Cathepsins and Their Involvement in Immune Responses
    Review article: Medical intelligence | Published 20 July 2010, doi:10.4414/smw.2010.13042 Cite this as: Swiss Med Wkly. 2010;140:w13042 Cathepsins and their involvement in immune responses Sébastien Conus, Hans-Uwe Simon Institute of Pharmacology, University of Bern, Bern, Switzerland Correspondence to: cleaving proteases (= caspases) which cleave a wide range Sébastien Conus Ph.D. of cellular substrates [5]. Institute of Pharmacology Besides caspases, cathepsins have recently been shown University of Bern to be associated with cell death regulation [6–12] and vari- Friedbühlstrasse 49 3010 Bern ous other physiological and pathological processes, such as Switzerland maturation of the MHC class II complex, bone remodel- [email protected] ling, keratinocyte differentiation, tumour progression and metastasis, rheumatoid arthritis and osteoarthritis, as well Summary as atherosclerosis [13, 14] (table 1). Thus, cathepsins ap- pear to play a significant role in immune responses. In this The immune system is composed of an enormous variety of review we discuss recent advances addressing the role of cells and molecules that generate a collective and coordin- lysosomal proteases in the diverse aspects of the immune ated response on exposure to foreign antigens, called the response, and also the involvement of cathepsins in the immune response. Within the immune response, endo-lyso- pathogenesis of diseases in which these proteases seem not somal proteases play a key role. In this review we cover to be properly under control. specific roles of cathepsins in innate and adaptive immu- nity, as well as their implication in the pathogenesis of sev- The cathepsin family eral diseases. Lysosomes are membrane-bound organelles which repres- Key words: adaptive and innate immunity; apoptosis; ent the main degradative compartment in eukaryotic cells.
    [Show full text]
  • Surface Cathepsin B Protects Cytotoxic Lymphocytes from Self-Destruction After Degranulation
    Surface Cathepsin B Protects Cytotoxic Lymphocytes from Self-destruction after Degranulation Kithiganahalli N. Balaji,1 Norbert Schaschke,2 Werner Machleidt,3 Marta Catalfamo,1 and Pierre A. Henkart1 1Experimental Immunology Branch, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892 2Max Planck Institut fur Biochemie, 82152 Martinsried, Germany 3Adolf Butenandt Institut fur Physiologische Chemie, Physikalische Biochemie und Zellbiologie, Ludwig Maximilians Universitat, 80336 Munich, Germany Abstract The granule exocytosis cytotoxicity pathway is the major molecular mechanism for cytotoxic T lymphocyte (CTL) and natural killer (NK) cytotoxicity, but the question of how these cyto- toxic lymphocytes avoid self-destruction after secreting perforin has remained unresolved. We show that CTL and NK cells die within a few hours if they are triggered to degranulate in the presence of nontoxic thiol cathepsin protease inhibitors. The potent activity of the imper- meant, highly cathepsin B–specific membrane inhibitors CA074 and NS-196 strongly impli- cates extracellular cathepsin B. CTL suicide in the presence of cathepsin inhibitors requires the granule exocytosis cytotoxicity pathway, as it is normal with CTLs from gld mice, but does not occur in CTLs from perforin knockout mice. Flow cytometry shows that CTLs express low to undetectable levels of cathepsin B on their surface before degranulation, with a substantial rapid increase after T cell receptor triggering. Surface cathepsin B eluted from live CTL after degranulation by calcium chelation is the single chain processed form of active cathepsin B. Degranulated CTLs are surface biotinylated by the cathepsin B–specific affinity reagent NS-196, which exclusively labels immunoreactive cathepsin B. These experiments support a model in which granule-derived surface cathepsin B provides self-protection for degranulating cytotoxic lymphocytes.
    [Show full text]
  • Cathepsin L2, a Novel Human Cysteine Proteinase Produced by Breast and Colorectal Carcinomas1
    [CANCERRESEARCH58,1624-1630, April 15. 19981 Advances in Brief Cathepsin L2, a Novel Human Cysteine Proteinase Produced by Breast and Colorectal Carcinomas1 Ifligo Santamarla, Gloria Velasco, Maite Cazorla, Antonio Fueyo, Elias Campo, and Carlos López-Otmn2 Departamento de Bioquimica y Biolog(a Molecular (I .S., G. V., C. L-O.J and Biolog(a Funcional (A F], Facultad de Medicina. Universidad de Oviedo, 33006 Oviedo. and Departamento de Anatom(a Patoldgica, Hospital Clmnico—Barcelona,08036Barcelona, [M. C., E. C.!, Spain Abstract (3); (b) cathepsin L (4); (c) cathepsin H (5); (d) cathepsin S (6); (e) cathepsin C (7); (/) cathepsin 0 (8); (g) cathepsin K (9); and (h) We have identified and cloned a new member of the papain family of cathepsin W (10). Furthermore, several groups have described the cysteine proteinases from a human brain eDNA library. The isolated existence of additional cysteine proteinases including cathepsins M, cDNA codes for a polypeptide of 334 amino acids that exhibits all of the structural features characteristic of cysteine proteinases, including the N, P. and T, which were originally identified because of their degrad active site cysteine residue essential for peptide hydrolysis. PairWise corn ing activity on specific substrates such as aldolase, collagen, prom parisons of this amino acid sequence with the remaining human cysteine sulin, or tyrosine aminotransferase, but whose characterization at the proteinases identified to date showed a high percentage of identity (78%) molecular level has not yet been reported (11—14). with cathepsin L; the percentage of identity with all other members of the Structural comparisons between the different members of the cys family was much lower (<40%).
    [Show full text]
  • 9232-Cathepsin F, Human Recombinant
    BioVision 03/16 For research use only Cathepsin F, human recombinant CATALOG NO: 9232-10 10 µg 9232-50 50 µg ALTERNATE NAMES: CATSF, CLN13, CTSF CONCENTRATION: 1 mg/ml (determined by Bradford assay) SOURCE: E.coli expressed recombinant CTSF protein, fused to His-tag at N- terminus PURITY: > 95% by SDS-PAGE MOL. WEIGHT: This protein is fused with 6x His tag at N terminus and the protein has a calculated MW of 26 kDa (237 aa). FORM: Liquid FORMULATION: In 20mM Tris-HCl buffer (pH 8.0) containing 0.4M Urea, 10% glycerol Human recombinant Cathepsin F STORAGE CONDITIONS: Store at +4°C for short term (1-2 weeks). For long term storage, aliquot and store at -70°C. Avoid repeated freezing and thawing RELATED PRODUCT: cycles. SEQUENCE: MGSSHHHHHH SSGLVPRGSH MGSAPPEWDW RSKGAVTKVK Cathepsin B, Active, human recombinant (Cat. No. 7580-50) DQGMCGSCWA FSVTGNVEGQ WFLNQGTLLS LSEQELLDCD KMDKACMGGL PSNAYSAIKN LGGLETEDDY SYQGHMQSCN Cathepsin D, Active, human recombinant (Cat. No. 9229-50) FSAEKAKVYI NDSVELSQNE QKLAAWLAKR GPISVAINAF Cathepsin K, Active, human recombinant (Cat. No. 7600-50) GMQFYRHGIS RPLRPLCSPW LIDHAVLLVG YGNRSDVPFW Cathepsin L, human recombinant (Cat. No. 1135-100) AIKNSWGTDW GEKGYYYLHR GSGACGVNTM ASSAVVD Cathepsin S, Active, human recombinant (Cat. No. 7526-50) DESCRIPTION: Cathepsin F, also known as CTSF, belongs to the cathepsin family. Human CellExp™ Cathepsin B, human recombinant (Cat. No. 7408-10) Cathepsins are papain family cysteine proteinases that represent a major component of the lysosomal proteolytic system. The CTSF Human CellExp™ Cathepsin D, human recombinant (Cat. No. 7409-10) gene is ubiquitously expressed, and it maps to chromosome Human CellExp™ Cathepsin L1, human recombinant (Cat.
    [Show full text]
  • Human Cathepsin F. Molecular Cloning, Functional Expression, Tissue Localization, and Enzymatic Characterization
    Human Cathepsin F. Molecular Cloning, Functional Expression, Tissue Localization, and Enzymatic Characterization The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Wang, Bruce, Guo-Ping Shi, Pin Mei Yao, Zhenqiang Li, Harold A. Chapman, and Dieter Brömme. 1998. “Human Cathepsin F: MOLECULAR CLONING, FUNCTIONAL EXPRESSION, TISSUE LOCALIZATION, AND ENZYMATIC CHARACTERIZATION.” Journal of Biological Chemistry 273 (48): 32000–8. doi:10.1074/ jbc.273.48.32000. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:41543161 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 273, No. 48, Issue of November 27, pp. 32000–32008, 1998 © 1998 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Human Cathepsin F MOLECULAR CLONING, FUNCTIONAL EXPRESSION, TISSUE LOCALIZATION, AND ENZYMATIC CHARACTERIZATION* (Received for publication, May 19, 1998, and in revised form, September 9, 1998) Bruce Wang‡§, Guo-Ping Shi§¶, Pin Mei Yao, Zhenqiang Li, Harold A. Chapman¶i, and Dieter Bro¨mmei From the Department of Human Genetics, Mount Sinai School of Medicine, CUNY, New York, New York 10029, the ¶Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115, and ‡Incyte Pharmaceuticals, Palo Alto, California 94080 A cDNA for a novel human papain-like cysteine prote- pressed, intracellular housekeeping proteases responsible for ase, designated cathepsin F, has been cloned from a the general lysosomal protein breakdown.
    [Show full text]
  • A Genomic Analysis of Rat Proteases and Protease Inhibitors
    A genomic analysis of rat proteases and protease inhibitors Xose S. Puente and Carlos López-Otín Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, 33006-Oviedo, Spain Send correspondence to: Carlos López-Otín Departamento de Bioquímica y Biología Molecular Facultad de Medicina, Universidad de Oviedo 33006 Oviedo-SPAIN Tel. 34-985-104201; Fax: 34-985-103564 E-mail: [email protected] Proteases perform fundamental roles in multiple biological processes and are associated with a growing number of pathological conditions that involve abnormal or deficient functions of these enzymes. The availability of the rat genome sequence has opened the possibility to perform a global analysis of the complete protease repertoire or degradome of this model organism. The rat degradome consists of at least 626 proteases and homologs, which are distributed into five catalytic classes: 24 aspartic, 160 cysteine, 192 metallo, 221 serine, and 29 threonine proteases. Overall, this distribution is similar to that of the mouse degradome, but significatively more complex than that corresponding to the human degradome composed of 561 proteases and homologs. This increased complexity of the rat protease complement mainly derives from the expansion of several gene families including placental cathepsins, testases, kallikreins and hematopoietic serine proteases, involved in reproductive or immunological functions. These protease families have also evolved differently in the rat and mouse genomes and may contribute to explain some functional differences between these two closely related species. Likewise, genomic analysis of rat protease inhibitors has shown some differences with the mouse protease inhibitor complement and the marked expansion of families of cysteine and serine protease inhibitors in rat and mouse with respect to human.
    [Show full text]
  • Analysis of Cysteine Cathepsin Knockout Mice in Cancer Models
    Chapter 15 Roles of Cysteine Proteases in Tumor Progression: Analysis of Cysteine Cathepsin Knockout Mice in Cancer Models Thomas Reinheckel*, Vasilena Gocheva*, Christoph Peters, and Johanna A. Joyce Abstract Cysteine cathepsins are a family of proteases that are frequently upregu- lated in various human cancers, including breast, prostate, lung, and brain. Indeed, elevated expression and/or activity of certain cysteine cathepsins correlates with increased malignancy and poor patient prognosis. In normal cells, cysteine cathe- psins are typically localized in lysosomes and other intracellular compartments, and are involved in protein degradation and processing. However, in certain diseases such as cancer, cysteine cathepsins are translocated from their intracellular com- partments to the cell surface and can be secreted into the extracellular milieu. Pharmacological studies and in vitro experiments have suggested general roles for the cysteine cathepsin family in distinct tumorigenic processes such as angio- genesis, proliferation, apoptosis, and invasion. Understanding which individual cathepsins are the key mediators, what their substrates are, and how they may be promoting these complex roles in cancer are important questions to address. Here, we discuss recent results that begin to answer some of these questions, illustrating in particular the lessons learned from studying several mouse models of multistage carcinogenesis, which have identified distinct, tissue-specific roles for individual cysteine cathepsins in tumor progression. T. Reinheckel, C. Peters Institut fu¨r Molekulare Medizin und Zellforschung, Albert-Ludwigs-Universita¨t, D-79104 Freiburg, Germany V. Gocheva, J.A. Joyce Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA * These authors made an equal contribution D.
    [Show full text]